AUPH vs SYF · P/E 28, rev $160.9M vs rev $11.19B
Aurinia Pharmaceuticals Inc (AUPH) versus SYF (SYF) — a side-by-side from cached financials, not a winner call.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
SYF (SYF) common stock.
Latest reported AUPH revenue for 2026-06-30 was $160.9M. Net income was $71.8M. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
Latest reported SYF revenue for 2026-06-30 was $11.19B. Net income was $1.69B. Revenue was up 99.6% from 2026-03-31 to 2026-06-30. SYF currently screens at market cap $0.
AUPH currently screens at market cap $1.03B and trailing P/E 28.1. SYF currently screens at market cap $0.
Not investment advice. Open the AUPH and SYF stock pages for the full models.
Not investment advice.